Vitamin K2 Comprehensive Study by Type (Vitamin K2 (20), Vitamin K2 (35), Vitamin K2 (45)), Application (Healthcare Products, Food & Beverages, Personal Care Products, Others), Form (Powder, Oil) Players and Region - Global Market Outlook to 2030

Vitamin K2 Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Vitamin K2
Vitamin K2, also know as menaquinone, is mostly found in diary products and mostly obtained from meat, cheese and eggs. Growing use of vitamin K2 in healthcare industry is expected to bolster its demand as it is one of the key ingredients in supporting cardiovascular health long-term. Also, the deficiency of K2 in new born and in people with malabsorption disorders are further attributing to its growth.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


is a semi consolidated market due to the presence of less players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that Chinese Vendors will contribute the maximum growth to Global Vitamin K2 market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Kappa Bioscience [Norway], NattoPharma [Norway], Gnosis [Italy], DSM [Netherlands], Viridis BioPharma [India], Frutarom [Israel], DuPont Nutrition & Health [Denmark], GeneFerm Biotechnology [Taiwan], Shanghai Reson Biotech [China], Guangdong Goodscend [China], Seebio Biotech [China] and Kyowa Hakko [Japan] are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Anderson Global Group [United States], NattoPharma USA, Inc [United States] and AlgaeCal [Canada].

Segmentation Overview
AMA Research has segmented the market of Global Vitamin K2 market by Type (Vitamin K2 (20), Vitamin K2 (35) and Vitamin K2 (45)), Application (Healthcare Products, Food & Beverages, Personal Care Products and Others) and Region.



On the basis of geography, the market of Vitamin K2 has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Powder will boost the Vitamin K2 market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Demand for Personalized Nutrition, Increasing Use of Vitamin K2 in Personal Care Products and People Inclination Towards Organic Vitamin K2 Source

Market Growth Drivers:
Growing Deficiencies of Vitamins K2 and Rising Health Awareness of Use of Vitamin K2

Challenges:
Growing Counterfeit Vitamins Market and Issues Related with Over Consumption During Disease

Restraints:
Lack of Awareness About Use of Vitamin K2 and Stringent Government Regulations Regarding Use of Vitamin K2

Opportunities:
Huge Potential of Vitamin K2 Application in Healthcare Sectors and Growing Awareness About Vitamin K2 Products in Emerging Countries

Market Leaders and their expansionary development strategies
In June 2022, Balchem agrees acquired vitamin K2 player Kappa Bioscience, This acquisition accelerates strategies focus and vision to healthier place.
In October 2022, Kappa Bioscience, a leading manufacturer of vitamin K2 under the brand name K2Vital, is introducing “the first” USDA organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications on the US market.


Key Target Audience
Vitamin K2 Manufacturers, Vitamin K2 Distributors/Traders/Wholesalers, Vitamin K2 Subcomponent Manufacturers, Industry Association, Downstream Vendors and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Vitamin K2 (20)
  • Vitamin K2 (35)
  • Vitamin K2 (45)
By Application
  • Healthcare Products
  • Food & Beverages
  • Personal Care Products
  • Others
By Form
  • Powder
  • Oil

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Deficiencies of Vitamins K2
      • 3.2.2. Rising Health Awareness of Use of Vitamin K2
    • 3.3. Market Challenges
      • 3.3.1. Growing Counterfeit Vitamins Market
      • 3.3.2. Issues Related with Over Consumption During Disease
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Personalized Nutrition
      • 3.4.2. Increasing Use of Vitamin K2 in Personal Care Products
      • 3.4.3. People Inclination Towards Organic Vitamin K2 Source
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vitamin K2, by Type, Application, Form and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Vitamin K2 (Value)
      • 5.2.1. Global Vitamin K2 by: Type (Value)
        • 5.2.1.1. Vitamin K2 (20)
        • 5.2.1.2. Vitamin K2 (35)
        • 5.2.1.3. Vitamin K2 (45)
      • 5.2.2. Global Vitamin K2 by: Application (Value)
        • 5.2.2.1. Healthcare Products
        • 5.2.2.2. Food & Beverages
        • 5.2.2.3. Personal Care Products
        • 5.2.2.4. Others
      • 5.2.3. Global Vitamin K2 by: Form (Value)
        • 5.2.3.1. Powder
        • 5.2.3.2. Oil
      • 5.2.4. Global Vitamin K2 Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Vitamin K2: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Kappa Bioscience [Norway]
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. NattoPharma [Norway]
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Gnosis [Italy]
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DSM [Netherlands]
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Viridis BioPharma [India]
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Frutarom [Israel]
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. DuPont Nutrition & Health [Denmark]
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GeneFerm Biotechnology [Taiwan]
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Shanghai Reson Biotech [China]
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Guangdong Goodscend [China]
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Seebio Biotech [China]
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Kyowa Hakko [Japan]
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Vitamin K2 Sale, by Type, Application, Form and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Vitamin K2 (Value)
      • 7.2.1. Global Vitamin K2 by: Type (Value)
        • 7.2.1.1. Vitamin K2 (20)
        • 7.2.1.2. Vitamin K2 (35)
        • 7.2.1.3. Vitamin K2 (45)
      • 7.2.2. Global Vitamin K2 by: Application (Value)
        • 7.2.2.1. Healthcare Products
        • 7.2.2.2. Food & Beverages
        • 7.2.2.3. Personal Care Products
        • 7.2.2.4. Others
      • 7.2.3. Global Vitamin K2 by: Form (Value)
        • 7.2.3.1. Powder
        • 7.2.3.2. Oil
      • 7.2.4. Global Vitamin K2 Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vitamin K2: by Type(USD Million)
  • Table 2. Vitamin K2 Vitamin K2 (20) , by Region USD Million (2018-2023)
  • Table 3. Vitamin K2 Vitamin K2 (35) , by Region USD Million (2018-2023)
  • Table 4. Vitamin K2 Vitamin K2 (45) , by Region USD Million (2018-2023)
  • Table 5. Vitamin K2: by Application(USD Million)
  • Table 6. Vitamin K2 Healthcare Products , by Region USD Million (2018-2023)
  • Table 7. Vitamin K2 Food & Beverages , by Region USD Million (2018-2023)
  • Table 8. Vitamin K2 Personal Care Products , by Region USD Million (2018-2023)
  • Table 9. Vitamin K2 Others , by Region USD Million (2018-2023)
  • Table 10. Vitamin K2: by Form(USD Million)
  • Table 11. Vitamin K2 Powder , by Region USD Million (2018-2023)
  • Table 12. Vitamin K2 Oil , by Region USD Million (2018-2023)
  • Table 13. South America Vitamin K2, by Country USD Million (2018-2023)
  • Table 14. South America Vitamin K2, by Type USD Million (2018-2023)
  • Table 15. South America Vitamin K2, by Application USD Million (2018-2023)
  • Table 16. South America Vitamin K2, by Form USD Million (2018-2023)
  • Table 17. Brazil Vitamin K2, by Type USD Million (2018-2023)
  • Table 18. Brazil Vitamin K2, by Application USD Million (2018-2023)
  • Table 19. Brazil Vitamin K2, by Form USD Million (2018-2023)
  • Table 20. Argentina Vitamin K2, by Type USD Million (2018-2023)
  • Table 21. Argentina Vitamin K2, by Application USD Million (2018-2023)
  • Table 22. Argentina Vitamin K2, by Form USD Million (2018-2023)
  • Table 23. Rest of South America Vitamin K2, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Vitamin K2, by Application USD Million (2018-2023)
  • Table 25. Rest of South America Vitamin K2, by Form USD Million (2018-2023)
  • Table 26. Asia Pacific Vitamin K2, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Vitamin K2, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Vitamin K2, by Application USD Million (2018-2023)
  • Table 29. Asia Pacific Vitamin K2, by Form USD Million (2018-2023)
  • Table 30. China Vitamin K2, by Type USD Million (2018-2023)
  • Table 31. China Vitamin K2, by Application USD Million (2018-2023)
  • Table 32. China Vitamin K2, by Form USD Million (2018-2023)
  • Table 33. Japan Vitamin K2, by Type USD Million (2018-2023)
  • Table 34. Japan Vitamin K2, by Application USD Million (2018-2023)
  • Table 35. Japan Vitamin K2, by Form USD Million (2018-2023)
  • Table 36. India Vitamin K2, by Type USD Million (2018-2023)
  • Table 37. India Vitamin K2, by Application USD Million (2018-2023)
  • Table 38. India Vitamin K2, by Form USD Million (2018-2023)
  • Table 39. South Korea Vitamin K2, by Type USD Million (2018-2023)
  • Table 40. South Korea Vitamin K2, by Application USD Million (2018-2023)
  • Table 41. South Korea Vitamin K2, by Form USD Million (2018-2023)
  • Table 42. Taiwan Vitamin K2, by Type USD Million (2018-2023)
  • Table 43. Taiwan Vitamin K2, by Application USD Million (2018-2023)
  • Table 44. Taiwan Vitamin K2, by Form USD Million (2018-2023)
  • Table 45. Australia Vitamin K2, by Type USD Million (2018-2023)
  • Table 46. Australia Vitamin K2, by Application USD Million (2018-2023)
  • Table 47. Australia Vitamin K2, by Form USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Vitamin K2, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Vitamin K2, by Application USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Vitamin K2, by Form USD Million (2018-2023)
  • Table 51. Europe Vitamin K2, by Country USD Million (2018-2023)
  • Table 52. Europe Vitamin K2, by Type USD Million (2018-2023)
  • Table 53. Europe Vitamin K2, by Application USD Million (2018-2023)
  • Table 54. Europe Vitamin K2, by Form USD Million (2018-2023)
  • Table 55. Germany Vitamin K2, by Type USD Million (2018-2023)
  • Table 56. Germany Vitamin K2, by Application USD Million (2018-2023)
  • Table 57. Germany Vitamin K2, by Form USD Million (2018-2023)
  • Table 58. France Vitamin K2, by Type USD Million (2018-2023)
  • Table 59. France Vitamin K2, by Application USD Million (2018-2023)
  • Table 60. France Vitamin K2, by Form USD Million (2018-2023)
  • Table 61. Italy Vitamin K2, by Type USD Million (2018-2023)
  • Table 62. Italy Vitamin K2, by Application USD Million (2018-2023)
  • Table 63. Italy Vitamin K2, by Form USD Million (2018-2023)
  • Table 64. United Kingdom Vitamin K2, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Vitamin K2, by Application USD Million (2018-2023)
  • Table 66. United Kingdom Vitamin K2, by Form USD Million (2018-2023)
  • Table 67. Netherlands Vitamin K2, by Type USD Million (2018-2023)
  • Table 68. Netherlands Vitamin K2, by Application USD Million (2018-2023)
  • Table 69. Netherlands Vitamin K2, by Form USD Million (2018-2023)
  • Table 70. Rest of Europe Vitamin K2, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Vitamin K2, by Application USD Million (2018-2023)
  • Table 72. Rest of Europe Vitamin K2, by Form USD Million (2018-2023)
  • Table 73. MEA Vitamin K2, by Country USD Million (2018-2023)
  • Table 74. MEA Vitamin K2, by Type USD Million (2018-2023)
  • Table 75. MEA Vitamin K2, by Application USD Million (2018-2023)
  • Table 76. MEA Vitamin K2, by Form USD Million (2018-2023)
  • Table 77. Middle East Vitamin K2, by Type USD Million (2018-2023)
  • Table 78. Middle East Vitamin K2, by Application USD Million (2018-2023)
  • Table 79. Middle East Vitamin K2, by Form USD Million (2018-2023)
  • Table 80. Africa Vitamin K2, by Type USD Million (2018-2023)
  • Table 81. Africa Vitamin K2, by Application USD Million (2018-2023)
  • Table 82. Africa Vitamin K2, by Form USD Million (2018-2023)
  • Table 83. North America Vitamin K2, by Country USD Million (2018-2023)
  • Table 84. North America Vitamin K2, by Type USD Million (2018-2023)
  • Table 85. North America Vitamin K2, by Application USD Million (2018-2023)
  • Table 86. North America Vitamin K2, by Form USD Million (2018-2023)
  • Table 87. United States Vitamin K2, by Type USD Million (2018-2023)
  • Table 88. United States Vitamin K2, by Application USD Million (2018-2023)
  • Table 89. United States Vitamin K2, by Form USD Million (2018-2023)
  • Table 90. Canada Vitamin K2, by Type USD Million (2018-2023)
  • Table 91. Canada Vitamin K2, by Application USD Million (2018-2023)
  • Table 92. Canada Vitamin K2, by Form USD Million (2018-2023)
  • Table 93. Mexico Vitamin K2, by Type USD Million (2018-2023)
  • Table 94. Mexico Vitamin K2, by Application USD Million (2018-2023)
  • Table 95. Mexico Vitamin K2, by Form USD Million (2018-2023)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Vitamin K2: by Type(USD Million)
  • Table 109. Vitamin K2 Vitamin K2 (20) , by Region USD Million (2025-2030)
  • Table 110. Vitamin K2 Vitamin K2 (35) , by Region USD Million (2025-2030)
  • Table 111. Vitamin K2 Vitamin K2 (45) , by Region USD Million (2025-2030)
  • Table 112. Vitamin K2: by Application(USD Million)
  • Table 113. Vitamin K2 Healthcare Products , by Region USD Million (2025-2030)
  • Table 114. Vitamin K2 Food & Beverages , by Region USD Million (2025-2030)
  • Table 115. Vitamin K2 Personal Care Products , by Region USD Million (2025-2030)
  • Table 116. Vitamin K2 Others , by Region USD Million (2025-2030)
  • Table 117. Vitamin K2: by Form(USD Million)
  • Table 118. Vitamin K2 Powder , by Region USD Million (2025-2030)
  • Table 119. Vitamin K2 Oil , by Region USD Million (2025-2030)
  • Table 120. South America Vitamin K2, by Country USD Million (2025-2030)
  • Table 121. South America Vitamin K2, by Type USD Million (2025-2030)
  • Table 122. South America Vitamin K2, by Application USD Million (2025-2030)
  • Table 123. South America Vitamin K2, by Form USD Million (2025-2030)
  • Table 124. Brazil Vitamin K2, by Type USD Million (2025-2030)
  • Table 125. Brazil Vitamin K2, by Application USD Million (2025-2030)
  • Table 126. Brazil Vitamin K2, by Form USD Million (2025-2030)
  • Table 127. Argentina Vitamin K2, by Type USD Million (2025-2030)
  • Table 128. Argentina Vitamin K2, by Application USD Million (2025-2030)
  • Table 129. Argentina Vitamin K2, by Form USD Million (2025-2030)
  • Table 130. Rest of South America Vitamin K2, by Type USD Million (2025-2030)
  • Table 131. Rest of South America Vitamin K2, by Application USD Million (2025-2030)
  • Table 132. Rest of South America Vitamin K2, by Form USD Million (2025-2030)
  • Table 133. Asia Pacific Vitamin K2, by Country USD Million (2025-2030)
  • Table 134. Asia Pacific Vitamin K2, by Type USD Million (2025-2030)
  • Table 135. Asia Pacific Vitamin K2, by Application USD Million (2025-2030)
  • Table 136. Asia Pacific Vitamin K2, by Form USD Million (2025-2030)
  • Table 137. China Vitamin K2, by Type USD Million (2025-2030)
  • Table 138. China Vitamin K2, by Application USD Million (2025-2030)
  • Table 139. China Vitamin K2, by Form USD Million (2025-2030)
  • Table 140. Japan Vitamin K2, by Type USD Million (2025-2030)
  • Table 141. Japan Vitamin K2, by Application USD Million (2025-2030)
  • Table 142. Japan Vitamin K2, by Form USD Million (2025-2030)
  • Table 143. India Vitamin K2, by Type USD Million (2025-2030)
  • Table 144. India Vitamin K2, by Application USD Million (2025-2030)
  • Table 145. India Vitamin K2, by Form USD Million (2025-2030)
  • Table 146. South Korea Vitamin K2, by Type USD Million (2025-2030)
  • Table 147. South Korea Vitamin K2, by Application USD Million (2025-2030)
  • Table 148. South Korea Vitamin K2, by Form USD Million (2025-2030)
  • Table 149. Taiwan Vitamin K2, by Type USD Million (2025-2030)
  • Table 150. Taiwan Vitamin K2, by Application USD Million (2025-2030)
  • Table 151. Taiwan Vitamin K2, by Form USD Million (2025-2030)
  • Table 152. Australia Vitamin K2, by Type USD Million (2025-2030)
  • Table 153. Australia Vitamin K2, by Application USD Million (2025-2030)
  • Table 154. Australia Vitamin K2, by Form USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Vitamin K2, by Type USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Vitamin K2, by Application USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Vitamin K2, by Form USD Million (2025-2030)
  • Table 158. Europe Vitamin K2, by Country USD Million (2025-2030)
  • Table 159. Europe Vitamin K2, by Type USD Million (2025-2030)
  • Table 160. Europe Vitamin K2, by Application USD Million (2025-2030)
  • Table 161. Europe Vitamin K2, by Form USD Million (2025-2030)
  • Table 162. Germany Vitamin K2, by Type USD Million (2025-2030)
  • Table 163. Germany Vitamin K2, by Application USD Million (2025-2030)
  • Table 164. Germany Vitamin K2, by Form USD Million (2025-2030)
  • Table 165. France Vitamin K2, by Type USD Million (2025-2030)
  • Table 166. France Vitamin K2, by Application USD Million (2025-2030)
  • Table 167. France Vitamin K2, by Form USD Million (2025-2030)
  • Table 168. Italy Vitamin K2, by Type USD Million (2025-2030)
  • Table 169. Italy Vitamin K2, by Application USD Million (2025-2030)
  • Table 170. Italy Vitamin K2, by Form USD Million (2025-2030)
  • Table 171. United Kingdom Vitamin K2, by Type USD Million (2025-2030)
  • Table 172. United Kingdom Vitamin K2, by Application USD Million (2025-2030)
  • Table 173. United Kingdom Vitamin K2, by Form USD Million (2025-2030)
  • Table 174. Netherlands Vitamin K2, by Type USD Million (2025-2030)
  • Table 175. Netherlands Vitamin K2, by Application USD Million (2025-2030)
  • Table 176. Netherlands Vitamin K2, by Form USD Million (2025-2030)
  • Table 177. Rest of Europe Vitamin K2, by Type USD Million (2025-2030)
  • Table 178. Rest of Europe Vitamin K2, by Application USD Million (2025-2030)
  • Table 179. Rest of Europe Vitamin K2, by Form USD Million (2025-2030)
  • Table 180. MEA Vitamin K2, by Country USD Million (2025-2030)
  • Table 181. MEA Vitamin K2, by Type USD Million (2025-2030)
  • Table 182. MEA Vitamin K2, by Application USD Million (2025-2030)
  • Table 183. MEA Vitamin K2, by Form USD Million (2025-2030)
  • Table 184. Middle East Vitamin K2, by Type USD Million (2025-2030)
  • Table 185. Middle East Vitamin K2, by Application USD Million (2025-2030)
  • Table 186. Middle East Vitamin K2, by Form USD Million (2025-2030)
  • Table 187. Africa Vitamin K2, by Type USD Million (2025-2030)
  • Table 188. Africa Vitamin K2, by Application USD Million (2025-2030)
  • Table 189. Africa Vitamin K2, by Form USD Million (2025-2030)
  • Table 190. North America Vitamin K2, by Country USD Million (2025-2030)
  • Table 191. North America Vitamin K2, by Type USD Million (2025-2030)
  • Table 192. North America Vitamin K2, by Application USD Million (2025-2030)
  • Table 193. North America Vitamin K2, by Form USD Million (2025-2030)
  • Table 194. United States Vitamin K2, by Type USD Million (2025-2030)
  • Table 195. United States Vitamin K2, by Application USD Million (2025-2030)
  • Table 196. United States Vitamin K2, by Form USD Million (2025-2030)
  • Table 197. Canada Vitamin K2, by Type USD Million (2025-2030)
  • Table 198. Canada Vitamin K2, by Application USD Million (2025-2030)
  • Table 199. Canada Vitamin K2, by Form USD Million (2025-2030)
  • Table 200. Mexico Vitamin K2, by Type USD Million (2025-2030)
  • Table 201. Mexico Vitamin K2, by Application USD Million (2025-2030)
  • Table 202. Mexico Vitamin K2, by Form USD Million (2025-2030)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vitamin K2: by Type USD Million (2018-2023)
  • Figure 5. Global Vitamin K2: by Application USD Million (2018-2023)
  • Figure 6. Global Vitamin K2: by Form USD Million (2018-2023)
  • Figure 7. South America Vitamin K2 Share (%), by Country
  • Figure 8. Asia Pacific Vitamin K2 Share (%), by Country
  • Figure 9. Europe Vitamin K2 Share (%), by Country
  • Figure 10. MEA Vitamin K2 Share (%), by Country
  • Figure 11. North America Vitamin K2 Share (%), by Country
  • Figure 12. Global Vitamin K2 share by Players 2023 (%)
  • Figure 13. Global Vitamin K2 share by Players (Top 3) 2023(%)
  • Figure 14. Global Vitamin K2 share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Kappa Bioscience [Norway] Revenue, Net Income and Gross profit
  • Figure 17. Kappa Bioscience [Norway] Revenue: by Geography 2023
  • Figure 18. NattoPharma [Norway] Revenue, Net Income and Gross profit
  • Figure 19. NattoPharma [Norway] Revenue: by Geography 2023
  • Figure 20. Gnosis [Italy] Revenue, Net Income and Gross profit
  • Figure 21. Gnosis [Italy] Revenue: by Geography 2023
  • Figure 22. DSM [Netherlands] Revenue, Net Income and Gross profit
  • Figure 23. DSM [Netherlands] Revenue: by Geography 2023
  • Figure 24. Viridis BioPharma [India] Revenue, Net Income and Gross profit
  • Figure 25. Viridis BioPharma [India] Revenue: by Geography 2023
  • Figure 26. Frutarom [Israel] Revenue, Net Income and Gross profit
  • Figure 27. Frutarom [Israel] Revenue: by Geography 2023
  • Figure 28. DuPont Nutrition & Health [Denmark] Revenue, Net Income and Gross profit
  • Figure 29. DuPont Nutrition & Health [Denmark] Revenue: by Geography 2023
  • Figure 30. GeneFerm Biotechnology [Taiwan] Revenue, Net Income and Gross profit
  • Figure 31. GeneFerm Biotechnology [Taiwan] Revenue: by Geography 2023
  • Figure 32. Shanghai Reson Biotech [China] Revenue, Net Income and Gross profit
  • Figure 33. Shanghai Reson Biotech [China] Revenue: by Geography 2023
  • Figure 34. Guangdong Goodscend [China] Revenue, Net Income and Gross profit
  • Figure 35. Guangdong Goodscend [China] Revenue: by Geography 2023
  • Figure 36. Seebio Biotech [China] Revenue, Net Income and Gross profit
  • Figure 37. Seebio Biotech [China] Revenue: by Geography 2023
  • Figure 38. Kyowa Hakko [Japan] Revenue, Net Income and Gross profit
  • Figure 39. Kyowa Hakko [Japan] Revenue: by Geography 2023
  • Figure 40. Global Vitamin K2: by Type USD Million (2025-2030)
  • Figure 41. Global Vitamin K2: by Application USD Million (2025-2030)
  • Figure 42. Global Vitamin K2: by Form USD Million (2025-2030)
  • Figure 43. South America Vitamin K2 Share (%), by Country
  • Figure 44. Asia Pacific Vitamin K2 Share (%), by Country
  • Figure 45. Europe Vitamin K2 Share (%), by Country
  • Figure 46. MEA Vitamin K2 Share (%), by Country
  • Figure 47. North America Vitamin K2 Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Kappa Bioscience [Norway]
  • NattoPharma [Norway]
  • Gnosis [Italy]
  • DSM [Netherlands]
  • Viridis BioPharma [India]
  • Frutarom [Israel]
  • DuPont Nutrition & Health [Denmark]
  • GeneFerm Biotechnology [Taiwan]
  • Shanghai Reson Biotech [China]
  • Guangdong Goodscend [China]
  • Seebio Biotech [China]
  • Kyowa Hakko [Japan]
Additional players considered in the study are as follows:
Anderson Global Group [United States] , NattoPharma USA, Inc [United States] , AlgaeCal [Canada]
Select User Access Type

Key Highlights of Report


Jan 2024 212 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Kappa Bioscience [Norway], NattoPharma [Norway], Gnosis [Italy], DSM [Netherlands], Viridis BioPharma [India], Frutarom [Israel], DuPont Nutrition & Health [Denmark], GeneFerm Biotechnology [Taiwan], Shanghai Reson Biotech [China], Guangdong Goodscend [China], Seebio Biotech [China] and Kyowa Hakko [Japan] etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Demand for Personalized Nutrition " is seen as one of major influencing trends for Vitamin K2 Market during projected period 2023-2030.
The Vitamin K2 market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Vitamin K2 Market Report?